Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

Jaap Verweij(Erasmus MC), Paolo G. Casali(Fondazione IRCCS Istituto Nazionale dei Tumori), John Zalcberg(Peter MacCallum Cancer Centre), A. Lecesne(Institut Gustave Roussy), Peter Reichardt(Charité - Universitätsmedizin Berlin), Jean‐Yves Blay(Centre de Recherche en Cancérologie de Lyon), Rolf D. Issels, A. van Oosterom, Pancras C.W. Hogendoorn(Leiden University Medical Center), M. van Glabbeke(European Organisation for Research and Treatment of Cancer), Rossella Bertulli(Fondazione IRCCS Istituto Nazionale dei Tumori), Ian Judson(Royal Marsden Hospital)
The Lancet
September 1, 2004
Cited by 1,668

Abstract


Related Papers

No related papers found

Powered by citation graph analysis